Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Quark Pharmaceuticals Announces Data Indicating Potential Utility Of QPI-1007 For Treatment Of Glaucoma
Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, announced data suggesting that QPI-1007 prevents progressive retinal ganglion cell (RGC) loss in an increased ocular pressure (IOP) rat model of glaucoma. The experiments performed by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal, indicate that QPI-1007 has the potential to treat patients with glaucoma. QPI-1007 is being evaluated in advanced IND-enabling preclinical studies as a neuroprotective agent for eye diseases.

Low Oxygen Levels In Prostate Tumors Can Predict Recurrence: Long-Term Study
Fox Chase Cancer Center researchers have discovered that low-oxygen regions in prostate tumors can be used to predict a rise in prostate-specific antigen (PSA) levels, a marker of tumor recurrence in prostate cancer. The long-term study results were presented at the 2009 American Society of Clinical Oncology annual meeting in Orlando, FL.
News of the day
Special Issue Of Criminology And Criminal Justice Explores Gun Crime Internationally
Guns smuggled from the US arm criminals in Canada and Mexico, contributing to a higher murder rate in Canada and more intense drug crime conflict near the Mexican border, according to a study published in a special issue of Criminology and Criminal Justice, published by SAGE.
Cardiovascular

New Journal To Be Published By SAGE In 2010: Social Psychological And Personality Science

SAGE, the world"s fifth largest publisher of academic journals, is pleased to announce the January 2010 launch of a new quarterly journal, Social Psychological and Personality Science (SPPS). SPPS will publish cutting-edge, short reports of single studies, or very succinct reports of multiple studies. The journal"s brief, to-the-point research articles will be of broad interest to both professional and lay audiences and will be written in a format accessible to a wide range of readers, including science writers for the popular press. It will feature a speedy review and publication process to allow groundbreaking research to be published quickly. SPPS is being published in partnership with the Association for Research in Personality, the European Association of Social Psychology, the Society of Experimental and Social Psychology, and the Society for Personality and Social Psychology, as well as other co-sponsors that will be announced soon. The more than 6,000 social and personality psychology scholars worldwide who are members of the founding societies will receive SPPS as a benefit of membership. "Social Psychological and Personality Science (SPPS) fills an important niche for social and personality researchers: It will allow us to communicate cutting edge developments in the field quickly, to a very large audience, and one certain to grow as we add additional scholarly societies from around the world as sponsors of the journal," said Linda Skitka, Professor of Psychology at the University of Illinois at Chicago, and the chairperson of the consortium of societies who founded the journal in cooperation with SAGE. SAGE also publishes the highly-ranked Personality and Social Psychology Bulletin and Personality and Social Psychology Review on behalf of the Society for Personality and Social Psychology. "No current journal focuses uniquely on social psychological and personality research using a fast-track that enables cutting-edge developments to be made quickly available," said Alison Mudditt SAGE Executive Vice President, Higher Education Group. "We"re very pleased to now be able to provide this new outlet for high quality social psychological and personality research with Social Psychological and Personality Science." Jim Gilden SAGE Publications


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009